首页 › 基金 › ARMISTICE CAPITAL, LLC › MDGL
ARMISTICE CAPITAL, LLC 对 MDGL 的持仓历史
MADRIGAL PHARMACEUTICALS INC · 医疗保健
ARMISTICE CAPITAL, LLC 在 Q3 2026 的 13F 申报中披露持有 MDGL(MADRIGAL PHARMACEUTICALS INC)92,024 股,市值约 US$46.4M,约占其申报组合的 0.63%,在其申报持仓中市值排名第 14 位。 ARMISTICE CAPITAL, LLC 最近 13 个申报季度中有 13 个季度披露了 MDGL 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
ARMISTICE CAPITAL, LLC 对 MDGL 的持仓演变
ARMISTICE CAPITAL, LLC 于 Q3 2023 首次披露 MDGL 持仓:108,000 股(约 US$15.8M)。 该持仓在 Q4 2025 达到峰值 265,705 股,市值约 US$154.7M。 在 13 次申报中,ARMISTICE CAPITAL, LLC 6 次增持、5 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 92,024 股、市值约 US$46.4M,环比减持 -195,976 股。。 持仓曾出现大幅变动:Q1 2024 增持约 236% (随后一个季度股价上涨 5%)、Q4 2024 增持约 100% (随后一个季度股价上涨 7%)、Q3 2025 增持约 102% (随后一个季度股价上涨 27%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 108.00K | $15.77M | 新进 |
| Q4 2023 | 50.00K | $11.57M | 减持 |
| Q1 2024 | 168.00K | $44.86M | 增持 |
| Q2 2024 | 150.00K | $42.02M | 减持 |
| Q3 2024 | 49.91K | $10.59M | 减持 |
| Q4 2024 | 100.00K | $30.86M | 增持 |
| Q1 2025 | 135.88K | $45.01M | 增持 |
| Q2 2025 | 124.00K | $37.53M | 减持 |
| Q3 2025 | 249.98K | $114.66M | 增持 |
| Q4 2025 | 265.70K | $154.73M | 增持 |
| Q1 2026 | 264.58K | $138.50M | 持有 |
| Q2 2026 | 288.00K | $154.64M | 增持 |
| Q3 2026 | 92.02K | $46.38M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MDGL 与 13F 数据
MDGL(MADRIGAL PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 46 只申报持有 MDGL,申报仓位最大的包括:BAKER BROS. ADVISORS LP (US$1.15B), 骏利亨德森集团 (US$1.05B), Jupiter Topco LLC (US$1.04B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MDGL 的基金
- BAKER BROS. ADVISORS LP 2.14M 股 · $1.15B · Q2 2026
- 骏利亨德森集团 2.02M 股 · $1.05B · Q1 2026
- Jupiter Topco LLC 1.94M 股 · $1.04B · Q2 2026
- Avoro Capital Advisors LLC 1.83M 股 · $923.93M · Q3 2026
- 保尔森基金 1.34M 股 · $719.52M · Q2 2026
- PAULSON & CO. INC. 1.34M 股 · $719.52M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 337.04K 股 · $169.85M · Q3 2026
- RTW INVESTMENTS, LP 312.82K 股 · $157.65M · Q3 2026
- Rock Springs Capital Management LP 177.25K 股 · $89.33M · Q3 2026
- Hood River Capital Management LLC 170.68K 股 · $86.02M · Q3 2026
更多关于 ARMISTICE CAPITAL, LLC
常见问题
How long has ARMISTICE CAPITAL, LLC held MDGL?
ARMISTICE CAPITAL, LLC has disclosed MDGL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ARMISTICE CAPITAL, LLC's current position in MDGL?
As of Q3 2026, ARMISTICE CAPITAL, LLC holds 92.02K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $46.38M, representing 0.63% of its reported portfolio and ranking #14.
Has ARMISTICE CAPITAL, LLC been buying or selling MDGL?
In the latest 13F filing (Q3 2026), ARMISTICE CAPITAL, LLC reduced its position in MDGL. The position peaked in Q4 2025 at 265.70K shares.
Which other funds hold MDGL?
Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, 骏利亨德森集团, Jupiter Topco LLC, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.